HSPG2 and B-cell chronic lymphocytic leukemia: In addition to mediating GC resistance in B-ALL, hypermorphic PLCγ2 mutations, which confer constitutive signaling have been shown to similarly induce drug resistance in chronic lymphocytic leukemia in which PLC signaling is important for survival and proliferation18,20,22,23.